Norepinephrine (NIC) and epinephrine (JO) uro metabolized extra** neuronally by cateehol-O-melhyl-trnnHfornHe to Liu; tnetanephrinos (JVINh), normotanephrine (NMN) and motnnophrino (MN), Subjects in this study received in(iihìoiih of tritium-labeled NIO and 10, Concen trations ofMNs and catecholamines won» measured in plasma flowing into and out of the heart, forearm, kidneys, mesenteric organs (gastrointestinal tract, spleen, and pancreas), liver, at\d adrenals to examine t'ho regional production ofMNs from circulating and locally released catecholamines. NIO spillover* from mesenteric organs and kidneys accounted (or (>4% of the spillover from all tissues. There was detectable spillover of 10 from most extraadrenal tissues, butHlW was from the adrenals. The production ofMNs irom locally released and circulating catecholamines varied widely among tissues. The liver made the lardosi contribution to removal of circulating NIO (57%) and 10 (¡Î2%) and the largest, contribution to the production ol'NMN ( 
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STIMA'IION of norepinophrino (Nl!) spillover into the circulation, using the dilution of iv infused | l|[]NIi with endogenous NH in plasma (i.e. the specific activity of plasma I '11|NK) provides a useful index of NK release from sympathetic nerves (I). Most released NH, however, is effi ciently removed by neuronal and exlraneuronal uptake, so that only a small portion escapes into the circulation (2) . Additional measurements of dihydroxyphenylglycol, the in traneuronal cleaminated metabolite of Nli, enable estimation of neuronal NK reuptake (3) (4) (5) . The metanephrines (MNs), nonnetanephrine (NMN) and metanephrine (MN) are ex traneuronal ( )-methylated metabolites of NIi and epineph rine (10; thus, measurements of their plasma concentrations enable examination of the exlraneuronal uptake and metab olism of catecholamines (6, 7) .
The above use of catecholamine metabolites to examine the neuronal and exlraneuronal disposition of catecholamines depends on measurements of specific activities of metabo lites and their precursor amines in plasma during the infu sion of '11-labeled catecholamines. In particular, differences in specific activities of Hi-labeled metabolites entering and leaving an organ are dependent on the relative amounts of metabolite derived from two sources: 1) metabolism of high specific activity catecholamine removed from in-flowing plasma, and 2) metabolism of locally released unlabeled catecholamine, This study applied the above considerations to examine the sources of plasma MNs and assess whether the extran euronal removal and metabolism of catecholamines vary * among different tissues. Concentrations of MNs and cat echolamines were measured in plasma flowing into and out of the heart, forearm, lungs, kidneys, adrenals, mesenteric organs, and liver. Samples of plasma draining mesenteric organs were obtained from the portal vein and, thus, rep resent plasma draining the gastrointestinal tract, spleen, and pancreas. Results in the intact innervated heart were com pared with those in patients with heart transplants, Dener vation of cardiac sympathetic nerves in these patients would be expected to produce little influence of locally released NK on the specific activity of [Jl I]NMN leaving the heart. observation room. All procedures were approved by the appropriate review committees, and all subjects gave informed written consent to participate in studies. Subjects examined in a cardiac catheterization laboratory included 7 normal volunteers (6 males and 1 female; 29-39 yr old), 20 patients with  angina pectoris with and without coronary artery disease (18 males and  2 females; 48-71 yr old), 39 patients with cardiac failure secondary to  coronary artery disease or idiopathic dilated cardiomyopathy (30 males  and 9 females; 33-75 yr old), 8 patients who had received heart trans plants '1 yr previously (7 males and 1 female; 28-64 yr old), 2 male patients with renal artery stenosis (55 and 62 yr old), and 1 male patient during inferior vena caval blood sampling for localization of a suspected pheochromocytoma (38 yr old). The latter patient was subsequently determined not to harbor a tumor. Patients with heart failure were receiving a variety of medications (typically some combination of cal cium channel blockers, digoxin, angiotensin-converting enzyme inhib itors, /3-blockers, nitrates, and diuretics) that were discontinued for 12 h before the study. Patients with heart transplants were receiving cyclosporine, azathioprine, and prednisone, Al other subjects remained unmedicated for at least 48 h before the studies.
S u b jects a n d M eth o d s
Patients studied during surgical anesthesia included five males and three females (47-77 yr old). The presence of a gastric adenocarcinoma provided the reason for surgery in seven patients, whereas a pancreatic neoplasm was the reason for surgery in the other patient. No signs of hepatic or distant metastases were found in any patient. Anesthesia was induced with sodium thiopental (3-5 m g/kg) and vecuronium bromide (1.5 mg/kg). Patients were intubated and mechanically ventilated with 30% oxygen and 70% nitrous oxide. Anesthesia was maintained with enflurane (0.5-0.7 minimum alveolar anesthetic concentration), fentanyl (2.5-3.0 g/kg), and midazolam (1 m g/kg) as needed.
Subjects studied in a patient observation room included five normal volunteers and five patients with essential hypertension (six males and four females; 28-47 yr old). All subjects were studied in the supine position, did not receive any medication for 2 weeks before the study, and hnd abstained from nicotine, alcohol, and caffeinated beverages for at least 12 h before the study. 
Infusions of tritium-labeled catecholamines

Blood sampling and blood flow determinations
Blood samples (10 mL) were collected into prechilled syringes at least 15 min after the start of radiotracer infusions. For patients studied in catheterization laboratories, blood samples (10 mL) were taken simul taneously from a radial or femoral artery and from the coronary sinus (n = 62), the pulmonary artery (n -36), or the right renal vein (n = 43). To examine MN production by the adrenals, blood samples were taken from an adrenal vein in four subjects and from the left and right renal veins in two subjects. In the latter subjects the catheter to the left kidney was advanced proximally to the vein draining the left adrenal so that the blood collected included effluent from both the left kidney and the left adrenal. Coronary sinus blood flow and cardiac output were determined by thermodilution, whereas renal blood flow was determined from the total body clearance and renal extraction of ^-aminohippurate.
For patients studied during surgical anesthesia, blood samples were taken simultaneously from a radial artery, the portal vein, and the right hepatic vein. Samples from the portal vein were taken by venipuncture, whereas those from the hepatic vein were taken using a catheter ad vanced to the site from a femoral vein. Blood flow through the hepatic artery and portal vein were measured using ultrasound transit time flow probes connected to a HT207 dual channel flowmeter (Transonic Systems, Ithaca, NY).
Studies carried out in a patient observation room involved simulta neous sampling of blood from a brachial artery and a deep antecubital vein. Forearm blood flow was measured using venous occlusion strain gauge plethysmography with circulation to the hand excluded by in flation of a wrist cuff to 100 mm Hg above systolic pressure for the duration of each blood flow determination.
Blood samples were collected into ice-cold tubes containing an an ticoagulant [heparin, ethylenediamine tetraacetate, or ethyleneglycolbis-(j3-aminoethyl eîher)-N,N,N' ,N'-tetrad ce tic acidl and stored on ice until studies were completed. Samples were then centrifuged at 4 C, and plasma was separated for storage at -8 0 C until assayed for plasma concentrations of catecholarnines and MNs.
Assays
The MNs (NMN and MN) were extracted from 2 mL plasma using solid phase ion exchange columns and quantified by liquid chroma tography with electrochemical detection (8) . The catecholamines (NE and E) were extracted from 1-mL samples of plasma using alumina and quantified by liquid chromatography with electrochemical detection (9) . Timed collections of eluants leaving the electrochemical cell, followed by liquid scintillation spectroscopy, enabled determination of plasma con centrations of 3H-labeled catecholamines and MNs. Interassay coeffi cients of variation were 12.2% for NMN, 11.2% for MN, 6.5% for NE, and 11.4% for E. Intraassay coefficients of variation were 4.2% for NMN, 3.3% for MN, 1.9% for NE, mid 3.0%; for E.
Calculations
The For a tissue with negligible local release of catecholamine the denervated transplanted heart or E in extraadrenal tissues), but which metabolizes circulating Yl-labeled and endogenous catecholamines to MNs, the specific activity of the ^H-labeled metabolite in out-flowing plasma (SA0) is dependent on the higher specific activity of the pHlcatecholamine precursor (SAC) and the lower specific activity of the 'ITlabeled metabolite (SAT ) in in-flowing plasma. Under the above condi tions, the proportion (pG) of metabolite in out-flowing plasma derived from metabolism of in-flowing catecholamine can be estimated accord ing to a previously described approach (10) The spillover of NMN or MN derived from local metabolism of the NE or E extracted from in-flowing plasma by the organ or tissue (SP) was then estimated using the equation S,> = (pc X fxc X C,) X F (Eq VII); all terms are described in Eq I, IV, and VI above. The spillover of NMN derived from metabolism of locally released NE was then estimated by subtraction of SP from the total spillover of NMN.
Plasma flows in the forearm were measured in units of milliliters per 100 mL tissue/miii, so that forearm spillovers have units of picomoles per 100 mL/min, Previously documented data about the density of skeletal muscle (12) and the mass of skeletal muscle in the body as a function of gender and body weight (13) were used to transform rates of catecholamine and MN spillover and removal for the forearm into rates for skeletal muscle throughout the body (units of picomoles per min). The above transformation assumes that spillovers from the fore arm reflect spillovers from skeletal muscle elsewhere in the body.
Rates of spillover of catecholamines and MNs from the adrenals were estimated using two methods. In the two patients from whom blood samples were obtained from the right renal vein and the common vein draining the left kidney and left adrenal gland, spillovers were estimated from the product of renal plasma flow and differences in catecholamine or MN concentrations at the two sampling sites. In the other patients from whom adrenal venous blood samples were obtained, adrenal sp illovers of catecholamines were estimated according to Eq V above. Adrenal spillovers of MNs were estimated similarly, except that no correction was made for fractional extractions, which were assumed to be negligible in relation to the arterial-venous increase in concentrations. Adrenal blood flow was assumed to equal 30 mL/min, as derived from previously documented data (14, 15).
StatisticaI methods
Results are expressed as means with variance for paired data (i.e. in-flowing and out-flowing plasma concentrations of MNs and frac tional extractions of NE and E) shown using sks of the difference and for other data using sum. Plasma concentrations of catecholamines and MNs are not normally distributed. Therefore, levels of statistical significance were determined using nonparametric methods; Wilcoxon's signed rank sum test was used for comparisons of paired data, and the MannWhitney test was used for comparisons of other data. Unless stated, statistical significance was defined as P < 0.05. 
R esu lts
Regional dijfcrenc.es in plasma MNs
There wa s a 12 ± 2% arteria 1-venous increase (P < in plasma concentrations of NMN across the heart (Table 1) . No other organ, apart from the adrenals, showed evidence of loca 1 production of NMN, as indicated by increases in NMN concentrations from in-flowing to out-flowing plasma. In contrast, concentrations of MN in in-flowing plasma were consistently higher (P < 0.01) than those in out-flowing plasma for every tissue, except the adrenals. The kidneys and liver showed the largest arterial-venous decreases (P < 0.005) in plasma MN. These organs also showed decreases (P < 0.01) in in-flowing to out-flowing plasma concentrations of NMN, indicating local extraction of both NMN and MN. Local production of MNs was most evident for the adrenals, which showed a 10-fold arterial-venous increase in plasma NMN and an 87-fold increase in plasma MN. Results represent mean plasma concentrations (picomoles per mL) with variance between inflowing and outflowing concentrations Bhown by the his of the difference (SED).
Handling of MNs by the transplanted and innervated heart
fi Significantly higher concentration in outflowing than inflowing plasma.
h Significantly lower concentration in outflowing than inflowing plasma, fairly consistent, increases (P < 0.002) in NM N from arterial to coronary venous plasma, patients with heart transplants showed consistent arterial-coronary venous decreases (P < 0.02) in plasma NM N (Fig, 1, top panel) . Plasma concentra tions of MN showed similar arterial-coronary venous de creases (P < 0.02) in both innervated control subjects and denervated heart transplant patients (Fig. I, bottom panel) . This and lack of a difference in arterial and coronary venous concentrations of [3I-I]MN resulted in a highly consistent 20,2 ± 2.2% increase (P < 0.001 ) in the specific activity of pH IM N from arterial to coronary venous plasma.
In contrast to the increase in specific activity of [3H]MN across the heart, control subjects showed a small, but con sistent, decrease (P < 0.001) in the specific activity of [nH]NMN from arterial to coronary venous plasma. On the other hand, heart transplant patients showed an increase (P < 0.03) in the specific activity of [3H]NM N from arterial to coronary venous plasm a (Fig. 2, lower panel) . Control subjects showed a large decrease (P < 0*001) in the specific activity of [3H]NE from arterial to coronary venous plasma, whereas patients with heart transplants showed a much smaller ar terial-venous decrease (P < 0.05) in the specific activity of l/tH]NE across the heart (Fig. 2, upper panel) .
The fractional extraction of PH]NE was decreased by 8' 1 % in patients with heart transplants compared to that in in nervated controls (0.70 ± 0.02 vs. 0.13 ± 0. sues, showed a large arterial-venous fall in the specific activity of plasma pHJMN (data not shown).
Changes in specific activities of [3H]NMN from in-flowing
Regional extractions of catecholamines to out-flowing plasma showed considerable variation among different tissues (Fig. 3) , Like the heart, mesenteric organs showed an arterial-*venous decrease (P < 0.02) in die specific activity of [3H]NMN, whereas increases (P < 0.02) in [3H]NMN specific activity were observed across the kidneys and liver. There were no differences in specific activities of [3H]NMN in the in-flowing and out-flowing plasma of the forearm and lungs.
In contrast to the variable changes in specific activities of [3H]NMN from in-flowing to out-flowing plasma of different tissues, specific activities of [3H]MN showed consistent in creases (P < 0.02) from in-flowing to out-flowing plasma for the heart, forearm, lungs, mesenteric organs, liver, and kid neys (Fig. 3) Fig. 3) showed a pattern similar to the differences in regional fractional extractions of [3H]E (Fig. 4) (Fig. 4) 
Fractional extractions of [31~I]NE showed variable differ ences from those of [3H]E, depending on the tissue
Regional extractions of M N
Fractional extractions of MN by the various organs and tissues were lower than those of the catecholamines, but, in general, showed similar variation among organs as the pre cursor amines ( Table 2 ). The highest fractional extraction of MN was in the liver; the lowest was in the lungs.
Regional removals and spillovers of catecholamines
Rates of NE spillover and removal showed wide variation among different tissues and organs (Table 3) . As expected, the adrenals showed the largest spillover of E, amounting to 91 % of the summed total ( Table 4) . The highest spillover rates of NE were observed for the kidneys and mesenteric organs, whereas the liver made the largest contribution to the re moval of circulating NE and E. Although there were large differences between NE spillover and removal rates among individual tissues, the sum of NE spillover rates for all tissues was similar to the sum of removal rates.
Regional metabolism of catecholamines to MNs
Only small proportions ( < 6%) of the E or NE extracted from the plasma entering the various organs and tissues appeared in the plasma effluent as MN or NM N (Tables 3 and  4) . Conversion of extracted catecholamines to MNs varied widely among tissues and organs; it was highest in the liver and lowest in the heart. Between 30-200% more MN ap peared in out-flowing plasma from extracted E than NM N from extracted NE.
Much more NM N was derived from the metabolism of locally released than circulating NE for all tissues, apart from the liver ( Table 3 Results represent the mean ± sem , Fractional extractions of MN were estimated from decreases in inflowing and outflowing plasma MN concentrations (see Table 1 However, only 19% of the N M N produced by all tissues was derived from metabolism of NE after entry into the circula tion; most (81%) was derived from metabolism of locally released NE before entry into the circulation. Regional sp illovers of NM N derived from locally released NE were typically a small fraction (3-13%) of NE spillovers; the ex ception to this was the adrenals, where NMN spillover was 33% that of NE spillover. The adrenals also m ade the single largest contribution (23%) to the spillover of NMN from all tissues.
The pattern of total and regional spillovers of MN derived from locally released and removed E (Table 4) showed some similarities to the pattern for NM N (Table 3) , but also many differences. Similar to the situation for NMN, the adrenals made the largest single contribution to the combined spill overs of M N from all organs and tissues; however, the extent of this contribution (91%) was much larger than that for NMN (23%).
Some spillover of E was detected from most organs and tissues, although far less than from the adrenals. Thus, like NMN, some spillover of MN from these extraadrenal tissues was derived from metabolism of locally released E (Table 4) . However, unlike the situation for NM N, all extra ad renal tissues produced more MN from E removed from the cir culation than from locally released E. Similar to the situation for NE and NMN, the liver m ade the single largest contri bution to removal of circulating E and produced the most MN from circulating E. However, metabolism of E after its release into the circulation made only a minor (6%) contri bution to total M N production, and only a small amount (3%) of MN was produced locally from E released by extraadrenal tissues. Most MN (91%) was formed by local metabolism of E produced within the adrenals.
D is c u s s io n
In addition to providing an examination of regional release and removal of NE and E, this study shows how the cat echolamines are metabolized to MNs after their local release within tissues or removal from the circulation. There are considerable differences in the production of MNs among various tissues. The adrenals in particular are an important source of MNs, providing an explanation for the extraordi nary sensitivity of these metabolites for the diagnosis of pheochromocytoma.
The lower concentrations of NMN in hepatic and right renal venous plasma than in arterial plasma agree with pre vious findings (16) , This and the extractioi^i of MN by all extraadrenal tissues indicate that assessment of regional pro duction of MNs, like catecholamines, requires consideration of their local removal. For catecholamines, this is achieved by analysis of arterial-venous decreases in the specific activity of iv infused 3H-labeled catecholamines (11) . The pro nounced decrease in the specific activity of [3H.]NE from arterial to coronary venous plasma in control subjects and the negligible decrease in heart transplant patients, who have little cardiac NE release (17) , illustrate how arterial-venous decreases in the specific activity of plasma [3H]NE reflect local release of endogenous NE, Differences in specific activities of [3H]NMN are more complex to interpret than those in l3H]NE, The decrease in specific activity of [3H]NE from in-flowing to out-flowing plasma is dependent only on local release of unlabeled NE, whereas any change in that of [3H]NMN is dependent on both metabolism of locally released NE and pITJNE removed from in-flowing plasma. Reversal of the normally observed arterial-coronary venous increase in plasma NMN to a de crease in heart transplant patients reflects the lack of cardiac NE release in these subjects; the resulting single source of NMN from in-flowing plasma NE together with the much higher specific activity of plasma [3H]NE than of [31-I]NMN results in an increase in the specific activity of [3H]NMN from arterial to coronary venous plasma. In the innervated heart, additional production of NMN from locally released unla beled NE results in an overall arterial-venous decrease in pH]NMN specific activity, Increases in specific activity of plasma [3H]MN across all tissues, except the adrenals, reflect a similar situation to the transplanted heart, where specific activity differences de pend on the extraction, but not the local release, of cat echolamines. The variable regional differences in specific activity of [3H]NMN reflect differences in the amounts of NMN derived from locally released or extracted NE. The liver, with the largest removal and smallest spillover of NE, also had the largest in-flowing to out-flowing increase in the specific activity of plasma PlTlNMN.
In all tissues, except the adrenals, regional spillovers of NMN were determined using the fractional extractions of MN, which were assumed to equal those of NMN. Fractional extractions of MN were determined after correction of the amount of locally extracted E converted to MN; it was as sumed that the amount of locally released E converted to MN was negligible. Both assumptions deserve comment. Similar total body clearances of NMN and MN and equal contribu tions of deamination to plasma clearances of both metabo lites (7) support the assumption of equivalent fractional ex tractions of MN and NMN. Further support is provided here by the similar fractional extractions of MN and NMN in transplanted hearts. The small, but detectable, spillover of E from extraadrenal tissues is in agreement with previous find Values represent the mean ± s e m rates (picomoles per min). Spillover rates of NE and total spillover rates of NMN were estimated according to Eq V in Materials and Methods. Removal rates of NE were estimated from the product of its fractional extraction, inflowing plasma concentration, and the plasma flow through the tissue. The spillover of NMN derived from local removal of plasma NE was estimated according to Eq VII in Materials and Methods. Subtraction of the latter estimate from the total spillover of NMN provided an estimate of the spillover of NMN derived from locally released NE. For the adrenals, estimates were derived without correction for the negligible influence of local extraction. Values represent the mean ± SEM rates (picomoles per min). Spillover and removal rates of E and spillover rates of MN derived from local removal of plasma E wore estimated as described in Table 3 for NE and NMN. The spillover of MN derived from locally released E was estimated from the product of the E spillover with the ratio of NMN spillover to NE spillover and the ratio of extracted E converted to MN to extracted NE converted to NMN. Total spillovers of MN were then estimated from the sum of MN spillovers derived from locally released and removed E, ings (2, 18) and suggests that some MN may be formed from locally released E. However, MN production from locally released E was less than that from extracted E, and the latter source influenced regional differences in plasma MN by only 2-10%. Therefore, the second assumption introduces negli gible error into estimates of MN extraction (<3% underes timation) for most tissues. In the liver, fractional extractions of MN may have been underestimated by up to 8%.
Larger regional production of MNs from extracted E than NE is in agreement with findings in rats (7, 19) and humans (20) , in which infusions of E and NE produced larger in creases in plasma MN than NMN, This is consistent with more efficient removal of E than NE by extraneuronal uptake and less efficient removal by neuronal uptake (2, 21, 22) . NE is also a better substrate than E for monoamine oxidase (23) . All of these differences contribute to greater availability of E than of NE for catechol-O-methyltransferase.
Larger fractions of NMN derived from locally released than circulating NE are consistent with findings in rats (19) and humans (20) that more NMN is produced from NE before than after its release into plasma. In humans, 16% of plasma NMN is derived from NE after its release into plasma (20) , a result close to the 19% contribution indicated here by the sum of regional NMN spillovers. In the liver, however, 60% of NMN is derived from plasma NE, reflecting the importance of this organ for the removal of circulating catecholamines.
Although most N M N derived from circulating NE is formed, in the liver, the most im portant single source of NM N is the adrenals. There is some previous evidence for an ad renal source of NMN; catechol-O-methyltransferase is present in adrenal tissue (24) , plasma NM N concentrations are lower in adrenalectomized patients than in control sub jects (20) , and plasma NM N concentrations are higher in the common vein draining the left kidney and the left adrenal gland than the vein draining the right kidney ('16). The present study extends these findings by showing 10-fold higher NM N concentrations in adrenal venous than arterial plasma and a 23% contribution of the adrenals to circulating NMN.
In humans, only 10% of the M N in plasma is derived from circulating E, suggesting that the other 90% is formed from O-methylation of E in the adrenals (20) , This conclusion is supported here by the 87-fold increase in plasma concentra tions of MN from arterial to adrenal venous plasma, which translates into a 91% contribution of the adrenals to the spillover of MN from all tissues.
The finding that the adrenals are a major source of circu lating M Ns has im portant implications for the use of these metabolites in the diagnosis of pheochromocytoma. The su periority of 24-h urinary excretion rates of MNs over other catecholamine metabolites for the diagnosis of pheochromo cytoma (25, 26) is explained not only by preferential metab olism of circulating catecholamines by extraneuronal path ways (10), but also by the primary source of MNs from chromaffin tissue. Other findings suggest that measurements of MNs in plasma provide a useful test for the presence of a pheochro mocytoma (8, 27, 28). Our own observations establish that measurements of plasma MNs offer a superior method for diagnosis of the tumor than measurements of plasma cat echolamines (29) . Even when quiescent and not releasing catecholamines, pheochromocytomas appear to actively me tabolize catecholamines to the O-methylated derivatives, re gardless of their adrenal or extraadrenal location.
MNs are produced extraneuronally, whereas cat echolamines are removed by neuronal and extraneuronal uptake (30) . Differences in the relative importance of neu ronal and extraneuronal uptake explain the small and highly variable amounts of NMN or MN produced by extraadrenal tissues relative to the amounts of NE or E removed from plasma. The heart, which removes NE largely by neuronal uptake (6), also produces the smallest fraction (0.77%) of NMN from extracted NE, In this study, the innervated heart removed 70% of the [3H]NE entering the coronary circula tion, whereas in cardiac transplant patients, only 13% was removed, presumably by extraneuronal uptake. If it is as sumed that the ratio of extraneuronal uptake to coronary venous outflow of [3H]NE is the same in transplanted and innervated hearts, then only 4.5% (13/87 of 30%) of in-flow ing NE and 6.4% (4.5% of 70%) of extracted NE is removed by extraneuronal uptake in innervated hearts. Thus, 12% (0.77% of 6.4%) of the NE removed by extraneuronal uptake appears in coronary venous plasma as NMN. Assuming a similar proportion for locally released NE indicates, from the total cardiac spillover of NMN (10.4 pm ol/m in), that extra neuronal uptake of NE is 87 pm ol/m in (10.4/0.12). Cardiac NE spillover is about 3 times this rate, and neuronal uptake is 10-fold that of NE spillover (5). Thus, extraneuronal up take removes a small portion (<4%) of the NE released by cardiac sympathetic nerves. This is less than the 10% estimated for the whole body (6)/ consistent with the greater importance of neuronal over extraneuronal uptake for removal of cat echolamines in the heart than in other tissues (21) .
Although this study provides a comprehensive examina tion of regional spillover and removal rates of MNs and catecholamines, it should be recognized that the data were obtained from a variety of patient groups studied under different conditions. Thus, some caution must be exercised in extrapolating the present comparisons among tissues to normal regional variations in sympathetic out-flow and cat echolamine metabolism. The present data, however, do in dicate wide regional variability in the extraneuronal pro duction of MNs from catecholamines released locally or removed from the circulation. The substantial contribution of the adrenals to production of MNs explains the extraordi nary sensitivity of these metabolites for the diagnosis of pheochromocytoma.
